Stephen L. Barman

Stephen L. Barman, MD

Began fellowship in 2015

Graduated in 2018


Initial post-graduate position:

Private Practice, Oklahoma Cancer Specialists & Research Institute, Tulsa, OK


BS, University of Illinois at Urbana-Champaign, Champaign, IL
MD, Ohio State University College of Medicine, Columbus, OH
Residency, University of Texas Southwestern, Dallas, TX


  • Evaluating Thrombocytopenia During Heparin Therapy
    Shen YM, Wolfe H, Barman S
    JAMA 2018 Feb 6;319(5):497-498
  • Choroid Plexus Papilloma - A Case Highlighting the Challenges of Extrapolating Pediatric Chemotherapy Regimens to Adult Populations
    Barman SL, Jean GW, Dinsfriend WM, Gerber DE
    J Oncol Pharm Pract 2016 Feb;22(1):170-4
  • A Reevaluation of CD22 Expression in Human Lung Cancer
    Pop LM, Barman S, Shao C, Poe JC, Venturi GM, Shelton JM, Pop IV, Gerber DE, Girard L, Liu XY, Behrens C, Rodriguez-Canales J, Liu H, Wistuba II, Richardson JA, Minna JD, Tedder TF, Vitetta ES
    Cancer Res 2014 Jan 1;74(1):263-71